Nonetheless, the inclusion of BARD1 in multigene panels for hereditary breast cancer testing remains justified, as BARD1 variants may contribute to cancer susceptibility, especially when considered in combination with other genetic or environmental factors [18]. Here, BARD1 is linked to breast carcinoma.